Exclusive data on GLP-1’s impact on UK food and drink consumption

Heath Week – 2

So far, many food and drink businesses have been sceptical that weight-loss drugs will have any major impact on them. But new studies show the opposite is true

So far, many food and drink businesses have been sceptical that weight-loss drugs will have any major impact on them. But new studies show the opposite is true.

Dismissed as a celebrity fad and an out-of-reach proposition for the bulk of core consumers, the food and drink industry has largely looked the other way amid the rapid rise of weight-loss drugs, other than a smattering of niche ‘GLP-1 friendly’ launches.

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW